Natural Relief for Acid Reflux

ISOThrive reduced or eliminated acid reflux symptoms in 88% of users

who self identified as having acid reflux symptoms once a week or more.

Join the thousands of customers who are getting real relief from ISOThrive!

“I suffered from acid reflux for years; started taking ISOThrive Prebiotic Nectar and the acid reflux completely went away.” M.M.

“I have a sensitive stomach and acid reflux…especially when I travel. Now that I’m taking ISOThrive, my recent trip was terrific in large part because my stomach never turned sour.C.C.

“In less than a month on ISOThrive Prebiotic Nectar my digestion is better, my bloating and gas are noticeably reduced and I am sleeping better.” N.S.

“Recently I was diagnosed with esophageal ulcers. Since taking ISOThrive daily, I’ve noticed a 75% improvement“. Dr. M.


Are you worried about long term side effects from medicines to treat symptoms?

Billions are being spent every year on medicines to treat acid reflux symptoms – but they don’t resolve the problem. And worse yet, there are potential long-term risks from these medicines.

Address and resolve the root cause instead

ISOThrive can help! The scientific literature has shown that people who suffer with symptoms of acid reflux often have an altered microbiome (dysbiosis) at the gastroesophageal junction.i, ii, iii These interloper bacteria have been shown to cause delayed gastric emptying and induce abnormal relaxation of the lower esophageal sphincteriv (the muscle that keeps the acid in your stomach).

Studies have also shown that people who suffer with these symptoms often have underlying local and systemic inflammationv, vi, vii and that inflammation causes further weakening of the esophageal muscle.viii

ISOThrive can help!

ISOThrive is a special type of microFood for the bacteria that live in our body and regulate our immune system. It is a lightly sweet nectar of MIMO (maltosyl-iso-malto-oligosaccharides), a zero-calorie complex carbohydrate.

Feeding the good bacteria (which love ISOThrive) can improve the composition of the microbiome,ix, x, xi help decrease systemic inflammationxii, xiii and get things back to normal.

Backed by science
Gastroenterologist recommended
Delicious nectar
No side-effects
Can be taken with other medications
Provides gut health benefits (reduced gas, bloating and digestive discomfort)

100% Money-Back Guarantee

A natural solution takes time to work. Try ISOThrive for 4 weeks. If you’re not satisfied, we’ll give you a full refund.


See if you qualify for a free trial Get Relief!

Please note: If you have a hiatal hernia or other physical conditions underlying your symptoms, ISOThrive may not be powerful enough to improve your symptoms.

References
i. Liying Yang et al., “Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the Microbiome,” Gastroenterology 137, no. 2 (2009): 588–97, doi:10.1053/j.gastro.2009.04.046.
ii. Liying Yang, Fritz Francois, and Zhiheng Pei, “Molecular Pathways: Pathogenesis and Clinical Implications of Microbiome Alteration in Esophagitis and Barrett Esophagus,” Clinical Cancer Research 18, no. 8 (2012).
iii. Liying Yang et al., “Microbiome in Reflux Disorders and Esophageal Adenocarcinoma.,” Cancer Journal (Sudbury, Mass.) 20, no. 3 (2014): 207–10, doi:10.1097/PPO.0000000000000044.
iv. Yang et al., “Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the Microbiome.”
v. Rhonda F. Souza et al., “Gastroesophageal Reflux Might Cause Esophagitis Through a Cytokine-Mediated Mechanism Rather Than Caustic Acid Injury,” Gastroenterology 137, no. 5 (November 2009): 1776–84, doi:10.1053/j.gastro.2009.07.055.
vi. Florian Rieder et al., “Inflammatory Mediators in Gastroesophageal Reflux Disease: Impact on Esophageal Motility, Fibrosis, and Carcinogenesis.,” American Journal of Physiology. Gastrointestinal and Liver Physiology 298, no. 5 (May 2010): G571–81, doi:10.1152/ajpgi.00454.2009.
vii. Kerry B. Dunbar et al., “Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes,” JAMA 315, no. 19 (May 17, 2016): 2104, doi:10.1001/jama.2016.5657.
viii. Karen M Harnett et al., “Viewpoints on Acid-Induced Inflammatory Mediators in Esophageal Mucosa,” Journal of Neurogastroenterology and Motility 16, no. 4 (October 31, 2010): 374–88, doi:10.5056/jnm.2010.16.4.374.
ix. Gustavo D. Pimentel, Thayana O. Micheletti, and Fernanda Pace, “Nutritional Targets for Modulation of the Microbiota in Obesity,” Drug Development Research 74, no. 6 (September 25, 2013): 393–402, doi:10.1002/ddr.21092.
x. Thea Scantlebury Manning and Glenn R Gibson, “Microbial-Gut Interactions in Health and Disease. Prebiotics.,” Best Practice & Research. Clinical Gastroenterology 18, no. 2 (April 1, 2004): 287–98, doi:10.1016/j.bpg.2003.10.008.
xi. Katherine Harmon Courage, “Fiber-Famished Gut Microbes Linked to Poor Health – Scientific American,” Scientific American, 2015, http://www.scientificamerican.com/article/fiber-famished-gut-microbes-linked-to-poor-health1/.
xii. Jelena Vulevic et al., “A Mixture of Trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults.,” The Journal of Nutrition 143, no. 3 (March 2013): 324–31, doi:10.3945/jn.112.166132.
xiii. Marcel Roberfroid et al., “Prebiotic Effects: Metabolic and Health Benefits.,” The British Journal of Nutrition 104 Suppl , no. Suppl 2 (August 1, 2010): S1–63, doi:10.1017/S0007114510003363.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.